Coronavirus LIVE Updates: Congress MP Anand Sharma hospitalised after testing positive for COVID-19
Firstpost 1 hour ago FP Staff
11:57 (IST)
Andhra Pradesh announces summer holidays for Classes 1 to 9
Andhra Pradesh government declared closure of academic year 2020-21 and announces summer holidays for Classes 1 to 9 from today for all schools functioning under all managements.
11:46 (IST)
New Delhi, Chandni Chowk metro stations closed
Entry for New Delhi and Chandni Chowk metro stations has been temporarily closed to ensure social distancing as part of crowd control measures. Exit is allowed from the stations.
11:33 (IST)
US CDC advises citizens against travel to India
Amid a surge in COVID cases in India, the United States Centers for Disease Control and Prevention advised its citizens to avoid all travel to India. Even fully vaccinated travellers may be at risk for getting and spreading variants and should avoid all travel to India. If yo
Global healthcare major Johnson & Johnson on Tuesday said it has sought approval from India s drug regulator to conduct a bridging clinical trial of its single-dose Covid-19 vaccine in the country.
The US Food and Drug Administration (USFDA) had in February approved Johnson & Johnson s Covid-19 vaccine that works with just one dose for emergency use. Johnson & Johnson is partnering with health authorities and the world s best scientists to provide the safety and efficacy data necessary to support worldwide emergency use of the Janssen Covid-19 vaccine candidate, the company said in a statement.
This comes close on the heels of the central government last week deciding to fast-track emergency approvals for all foreign produced coronavirus jabs that have been given a similar nod by the World Health Organization or regulators in the United States, Europe, Britain or Japan.
Global healthcare major Johnson & Johnson on Tuesday said it has sought an approval from the India s drug regulator to conduct a bridging clinical trial of its single-dose Covid-19 vaccine in the country. The US Food and Drug Administration (USFDA) had in February approved Johnson & Johnson s Covid-19 vaccine that works with just one dose for emergency use. Johnson & Johnson is partnering with health authorities and the world s best scientists to provide the safety and efficacy data necessary to support worldwide emergency use of the Janssen Covid-19 vaccine candidate, the company said ina statement. This comes close on the heels of the central government last week deciding to fast-track emergency approvals for all foreign produced coronavirus jabs that have been given a similar nod by the World Health Organization or regulators in the United States, Europe, Britain or Japan.